Synergistic Combination of Compounds and Advanced Technologies for Enhanced Coronavirus Treatment

The present inventive concept integrates patented compounds for treating coronavirus infections with cutting-edge technologies like AI, IoT, blockchain, and nanomaterials to create a more effective and efficient system for combating coronavirus-associated diseases.

The original patent disclosed compounds for treating coronavirus infections, but the treatment outcomes can be improved by leveraging advanced technologies to enhance the compounds' efficacy, monitor patients more effectively, and ensure secure distribution. The present inventive concept addresses these limitations by introducing synergistic combinations of the patented compounds with AI, IoT, blockchain, and nanomaterials.

The inventive concept comprises a compound represented by Formula I, wherein R1-R6 are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroalicyclic, and carbonyl. This compound is integrated with a machine learning module for predicting the efficacy of the compound in treating the disease, IoT sensors for monitoring the patient's vital signs, a blockchain-based platform for tracking the distribution and administration of the compound, and a nanomaterial for enhancing the compound's bioavailability. The machine learning module uses a deep learning model trained on a dataset of coronavirus-infected cells to predict the efficacy of the compound. The IoT sensors provide real-time monitoring of the patient's vital signs, enabling timely interventions. The blockchain-based platform ensures secure and transparent tracking of the compound's distribution and administration. The nanomaterial enhances the compound's bioavailability, leading to improved treatment outcomes.

The present inventive concept's novelty lies in the synergistic combination of the patented compounds with advanced technologies like AI, IoT, blockchain, and nanomaterials. The inventive step resides in the integration of these technologies to create a more effective and efficient system for combating coronavirus-associated diseases, which is not obvious from the original patent.

Alternative embodiments of the inventive concept may include using different machine learning algorithms, IoT sensor configurations, blockchain platforms, or nanomaterials. Variations may also include integrating the compound with other advanced technologies, such as robotics or augmented reality, to further enhance treatment outcomes.

The present inventive concept has significant commercial potential in the pharmaceutical and healthcare industries, particularly in the context of coronavirus pandemic management. The target market includes hospitals, clinics, and research institutions, as well as governments and public health organizations.